Loading viewer...
conference
Format: PDF conference
Nektar Therapeutics presented at Cowen & Company's 37th Annual Healthcare Conference in March 2017, highlighting its biopharmaceutical pipeline including ONZEALD for metastatic breast cancer, NKTR-181 abuse-deterrent opioid, and NKTR-214 IL-15 agonist. The company outlined integrated R&D capabilities across facilities in San Francisco, Huntsville, and Hyderabad, with projected revenue of $375-450M annually by 2021 from its partnered portfolio.
other
91 Pages
conference
21 Pages
Quotient Limited
Quanex Building Products 2017 CJS Securities Conference
conferenceconference
18 Pages
Quanex Building Products Corporation
IFRS 17 Implementation Timeline Solutions 2020
conferenceconference
33 Pages
Institute of Actuaries of India
Hyatt Hotels 2024 Conference Presentation - Orlando Property Sale
conferenceconference
3 Pages
Hyatt Hotels Corporation